Evolent Health, Inc.

Total Valuation

Evolent Health, Inc. carries a market capitalization of 395.93M, placing it among publicly traded companies globally. Its enterprise value stands at 1.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Evolent Health, Inc. currently has 112.68M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.29, and the price-to-book ratio stands at 1.59.

Enterprise Valuation

On an enterprise value basis, Evolent Health, Inc. trades at an EV/EBITDA multiple of 21.01 and an EV/FCF ratio of 9.56. The EV/Sales ratio of 0.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1,281.54 provides insight into valuation relative to core operating earnings.

Financial Position

Evolent Health, Inc. maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 253.23, indicating elevated leverage, while an interest coverage ratio of 1.02 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Evolent Health, Inc.'s stock has declined approximately -63.37149% over the past 52 weeks. The 50-day moving average sits at 4.28, while the 200-day moving average is 3.85.

Income Statement

Over the trailing twelve months, Evolent Health, Inc. generated 2.10B in revenue and converted that into -504.99M in net income, yielding earnings per share of -4.49. EBITDA reached 69.74M, while operating income came in at -42.03M.

Balance Sheet

Evolent Health, Inc. holds 115.70M in cash and equivalents against 970.43M in total debt, resulting in a net debt position of 850.76M. Total book value stands at 383.22M, with working capital of 117.68M providing operational flexibility.

Cash Flow

Evolent Health, Inc. produced 54.32M in operating cash flow over the past twelve months. After subtracting -29.98M in capital expenditures, free cash flow totaled 24.34M - equivalent to 0.22 per share.

Margins

Evolent Health, Inc. operates with a gross margin of 17.25, reflecting its pricing power and cost economics. The operating margin of -2.00 and net profit margin of -24.08 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 0.81 indicates the proportion of earnings distributed to shareholders.

Scores

Evolent Health, Inc. posts an Altman Z-Score of 0.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.